Chip Scarlett

Track

Insider profile

Currently holds positions in Geron Corp, Chiasma Inc and CytomX Therapeutics Inc

Performance

Overall performance
0.7
Performance over holding periods
0.7
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, President, Chief Executive Officer Geron Corp Dec. 27, 2018 -
Independent Director Chiasma Inc Feb. 1, 2015 -
Independent Director CytomX Therapeutics Inc June 10, 2016 -
President, Chief Executive Officer, Director Geron Corp Jan. 5, 2012 - Dec. 27, 2018
Chief Executive Officer, Director Geron Corp Sept. 29, 2011 - Jan. 5, 2012
Chip Scarlett's trades of Geron Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-03-03 2025-02-27
US Geron Corp (GERN)
B Purchase
21,701 -12.4%
453.16
US$1,721,411 		21,701 -12.4% 453.16 US$1,721,411
2024-06-05 2024-06-04
US Geron Corp (GERN)
PlS Planned sale
12,700 -36.1%
314.50
US$2,470,814 		12,700 -36.1% 314.50 US$2,470,814
2024-06-04 2024-06-04
US Geron Corp (GERN)
PrS Proposed sale
11,002
220.94
US$3,202,800 		11,002 220.94 US$3,202,800
2023-02-10 2023-02-10
US Geron Corp (GERN)
PlS Planned sale
446,668 -100.0%
3.00
US$1,340,004 		446,668 -100.0% 3.00 US$1,340,004
2023-02-10 2023-02-09
US Geron Corp (GERN)
PlS Planned sale
446,666 -100.0%
3.03
US$1,353,398 		446,666 -100.0% 3.03 US$1,353,398
2023-02-10 2023-02-08
US Geron Corp (GERN)
PlS Planned sale
446,666 -100.0%
3.08
US$1,375,731 		446,666 -100.0% 3.08 US$1,375,731